EVERSANA’s CEO Jim Lang has been honored with the PharmaVOICE Top 100 Commanders & Chiefs Award for the second consecutive year.
The PharmaVOICE 100 Award celebrates life sciences leaders who provide inspiration to their peers, colleagues and companies – all through innovative and motivational approaches to addressing industry challenges.
Lang was included on the PharmaVOICE 100 list this year for his “inspiring navigation of the COVID-19 pandemic,” among several other accomplishments. By encouraging and driving his team forward, EVERSANA continued to expand its global team and service offerings to meet patient needs and continues to do so.
Most recently, EVERSANA acquired Accelera Canada and its partner companies, Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Solutions, headquartered in Toronto, while also partnering to launch cutting-edge, life-changing treatments, such as a T-cell leukemia treatment with Shorla Pharma.
Lang will be honored with all PharmaVOICE Top 100 Commanders & Chiefs awardees on Thursday, Sept. 9, at the PharmaVOICE 100 Celebration. Read Lang’s PharmaVOICE feature here, and see the full list of award recipients here.